Home › Funds › CAXTON ASSOCIATES LLP › PGNY

CAXTON ASSOCIATES LLP position in PGNY

PROGYNY INC · Health Care

CAXTON ASSOCIATES LLP reported holding 293,287 shares of PGNY (PROGYNY INC) in its Q2 2026 13F filing — a position valued at US$8.5M, representing 0.16% of its reported portfolio and ranking #41 among its reported holdings. CAXTON ASSOCIATES LLP has disclosed PGNY holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

Latest position (Q2 2026)293.29K sh
Reported value held$8.46M
Portfolio Weight0.16%
First reportedQ1 2025
Last changeNew
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How CAXTON ASSOCIATES LLP's PGNY position evolved

CAXTON ASSOCIATES LLP first disclosed a stake in PGNY in Q1 2025 at 24,825 shares (US$555K). The position peaked in Q2 2026 at 293,287 shares, worth US$8.5M. Across 4 filings, CAXTON ASSOCIATES LLP increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 293,287 shares valued at US$8.5M. Notable position changes include a 41% trim in Q2 2025 (shares fell 2% over the following quarter), a 26% trim in Q3 2025 (shares rose 19% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2025 24.82K $554.59K New
Q2 2025 14.61K $321.35K Reduce
Q3 2025 10.81K $232.54K Reduce
Q2 2026 293.29K $8.46M New

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PGNY and 13F data

PGNY (PROGYNY INC) is a Health Care company. 27 other funds we track also report a position in PGNY — the largest reported positions include Soleus Capital Management, L.P. (US$46.2M), DISCIPLINED GROWTH INVESTORS INC /MN (US$34.1M), EASTERLY INVESTMENT PARTNERS LLC (US$27.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PGNY

All PGNY fund holders →

FAQ

How long has CAXTON ASSOCIATES LLP held PGNY?

CAXTON ASSOCIATES LLP has disclosed PGNY holdings in 4 of the last 6 reported quarters, going back to Q1 2025.

What is CAXTON ASSOCIATES LLP's current position in PGNY?

As of Q2 2026, CAXTON ASSOCIATES LLP holds 293.29K shares of PGNY (PROGYNY INC), valued at $8.46M, representing 0.16% of its reported portfolio and ranking #41.

Has CAXTON ASSOCIATES LLP been buying or selling PGNY?

In the latest 13F filing (Q2 2026), CAXTON ASSOCIATES LLP newly opened its position in PGNY. The position peaked in Q2 2026 at 293.29K shares.

Which other funds hold PGNY?

Other major institutional holders of PGNY include Soleus Capital Management, L.P., DISCIPLINED GROWTH INVESTORS INC /MN, EASTERLY INVESTMENT PARTNERS LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.